Unmesh Shah assists in the drafting and prosecution of U.S. and foreign patent applications as well as with due diligence and patentability analyses projects for pharmaceutical/biotechnology clients.
Prior to joining Jones Day, Unmesh worked as a medicinal chemist at Schering-Plough and Merck for 14 years. During his tenure in the pharmaceutical industry, he designed, synthesized, and advanced several drug candidates to clinical trials. Unmesh's experience in life science research covers several therapeutic areas, including infectious, central nervous system, cardiovascular, and metabolic disorders.
Unmesh conducted his doctoral research in the field of total synthesis of natural products. As part of his Ph.D. research, he successfully completed the first total synthesis of a complex alkaloid, himgaline and published this work in the Journal of the American Chemical Society. Unmesh has been a peer reviewer of scientific articles and is a lead author on a number of scientific publications, including invited review articles and book chapters. He is an inventor of approximately 12 granted U.S. patents and 19 published PCT applications. Additionally, Unmesh has given several oral and poster presentations at national meetings. He is a member of the American Chemical Society.
- Fordham University (J.D. 2019); Stevens Institute of Technology (Ph.D. in Organic Chemistry 2006; M.S. in Chemistry 2000); Gujarat University, India (M.Sc. in Organic Chemistry 1998); St. Xavier's College, India (B.Sc. in Chemistry 1996)
- New York